US trials for Microvision's display system:
This article was originally published in Clinica
Executive Summary
A US team at Baylor College of Medicine in Houston, Texas, plans to begin clinical studies using tools based on Microvision's retinal scanning display technology to improve surgical visualisation in minimally invasive cardiac and abdominal procedures. The trials, which are expected to start in the second half of 2000, will involve the development of an advanced head-mounted display system that will provide surgeons with an "inside the body view".
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.